BioSerenity Funding: $121M Raised, Series B (2023)

BioSerenity is based in Paris, France. It has raised $121M in total funding. Latest round: Series B. Backed by Kurma Partners, Idinvest Partners, LBO France.

BioSerenity funding overview

BioSerenity is based in Paris, France. BioSerenity has raised $121M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2023. The round record for BioSerenity runs through 2023; nothing later has been disclosed. Investors on record include Kurma Partners, Idinvest Partners, LBO France, Dassault Systems, Jolt Capital. 5 distinct backers are named across the disclosed rounds.

BioSerenity at a glance

Total raised
$121M
Latest round
Series B
Latest round date
November 2023
Headquarters
Paris, France
Notable investors
Kurma Partners, Idinvest Partners, LBO France, Dassault Systems, Jolt Capital

Frequently asked about BioSerenity funding

How much has BioSerenity raised?
BioSerenity has raised $121M in total disclosed funding across the rounds on record.
Who has invested in BioSerenity?
Kurma Partners, Idinvest Partners, LBO France, Dassault Systems, Jolt Capital are named among the investors backing BioSerenity.
What was the latest BioSerenity funding round?
The most recent disclosed round is a Series B, announced in November 2023.
Where is BioSerenity based?
BioSerenity is based in Paris, France.
When did BioSerenity last raise?
The last disclosed BioSerenity round closed in November 2023 at Series B.

We update the BioSerenity record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Paris and their backers are listed below.

Companies related to BioSerenity (36)

Browse related funding lists (8)

Company funding database · Investor directory · Founder database · Mega-rounds 2026